Results 61 to 70 of about 268,622 (261)

The Value of Multidetector Computed Tomography of Orbits in Globe Protrusion in Comparison to Hertel Exophthalmometry

Acta Clinica Croatica, 2017
The use of multidetector computed tomography (MDCT) is an integral part of contemporary diagnostics of Graves‘ orbitopathy. Th e aim of this study was to assess proptosis measurement by MDCT and to compare it to the current standard, Hertel ...
Igor Đorić, Miloš Žarković, Zoran Radojičić, Nikola Repac, Aleksandar Janićijević, Krešimir Rotim, Goran Tasić, Lukas Rasulić   +7 more
doaj   +1 more source

Differential Gene Expression Profiling of Orbital Adipose Tissue in Thyroid Orbitopathy [PDF]

, 2015
Published under a Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/legalcode)PURPOSE. We aimed to determine differentially expressed genes relevant to orbital inflammation and orbital fat
Burdon, Kathryn Penelope, Craig, Jamie E, Ebeling, Peter R, Hardy, Thomas G, Jung, Chol-Hee, Khong, Jwu Jin, Llamas, Bastien, McNab, Alan A, Selva, Dinesh, Sharma, Shiwani, Smyth, Gordon K, Wang, Lynn Yuning   +11 more
core   +1 more source

Endoscopic orbital decompression for Graves′ orbitopathy

Indian Journal of Endocrinology and Metabolism, 2013
Aim: To study the efficacy of endonasal endoscopic orbital decompression in cases of Graves′ orbitopathy. Material and Methods: A total of 24 orbits in 12 patients underwent endoscopic orbital decompression for graves orbitopathy in the period between ...
Priti Lal, Alok Thakar, Nikhil Tandon
doaj   +1 more source

The efficacy and safety of selenium supplementation versus placebo in the treatment of Graves' orbitopathy: A systematic review and meta‐analysis of randomised controlled trials

Clinical Endocrinology
Selenium is a trace element crucial for thyroid function, and has potential therapeutic benefits in Graves' orbitopathy (GO). Therefore, we aim to evaluate its efficacy and safety in GO patients to provide valuable insights into its role as a therapeutic
Israa Sharabati, R. Qafesha, M. Hindawi, S. Amro, Baraa M Ayesh   +4 more
semanticscholar   +1 more source

Increased percentage of L-selectin+ and ICAM-1+ peripheral blood CD4+/CD8+ T cells in active Graves' ophthalmopathy. [PDF]

, 2009
The purpose of the study was to evaluate the percentage of CD4+/CD8+ peripheral T cells expressing CD62L+ and CD54+ in patients with Graves' disease and to assess if these estimations could be helpful as markers of active ophthalmopathy.
A Bossowski, A De Bellis, A Heufelder, A Kretowski, A Modelska-Ziolkiewicz, A Pappa, A Pappa, Alina Bakunowicz-Lazarczyk, Anna Stasiak-Barmuta, G Foerster, G Kulig, G Liu, I Wakelkamp, I Wakelkamp, J Aniszewski, J Mysliwiec, Janusz Mysliwiec, L Bartalena, M Kazim, Maria Gorska, N Xia, P Boulos, Przemysław Pawlowski, R Bahn, S Yan, W Wiersinga   +25 more
core   +3 more sources

Muscle tendon elongation with bovine pericardium (Tutopatch®) in patients with Graves’ orbitopathy; a prospective, observational, multicentre study

Acta Ophthalmologica, EarlyView.
Abstract Purpose Patients with severe ocular motility restriction and/or large angle strabismus due to Graves' orbitopathy (GO) cannot be adequately addressed with conventional strabismus surgery using large muscle recessions. Muscle tendon elongation surgery, using a spacer of bovine pericardium (Tutopatch®) has emerged as a valuable alternative.
H. M. Jellema, M. Oeverhaus, A. Eckstein, I. Mombaerts, R. J. H. M. Kloos, D. T. Hartong, P. Nieuwkerk, P. Saeed   +7 more
wiley   +1 more source

A novel CD4+ CTL subtype characterized by chemotaxis and inflammation is involved in the pathogenesis of Graves’ orbitopathy

Cellular & Molecular Immunology, 2021
Graves’ orbitopathy (GO), the most severe manifestation of Graves’ hyperthyroidism (GH), is an autoimmune-mediated inflammatory disorder, and treatments often exhibit a low efficacy.
Yue Wang, Ziyi Chen, Tingjie Wang, Hui Guo, Yufeng Liu, Ningxin Dang, Shiqian Hu, Li-ping Wu, Chengsheng Zhang, K. Ye, B. Shi   +10 more
semanticscholar   +1 more source

Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease

Acta Ophthalmologica, EarlyView.
Abstract Purpose To examine ocular surface changes and inflammatory tear fluid biomarkers in patients with thyroid eye disease (TED). Methods We included 106 Graves' disease (GD) patients (36 without TED, 32 with active and 38 with inactive TED) and 106 age‐ and sex‐matched healthy subjects for ophthalmological evaluation, including ocular surface ...
Mikael Thomassen Neset, Roy Miodini Nilsen, Kristian Løvås, Kathrine Halsøy, Håkon Reikvam, Ann‐Elin Meling Stokland, Grethe Åstrøm Ueland, Anette S. B. Wolff, Hans Christian D. Aass, Sjur Reppe, Eystein Sverre Husebye, Eyvind Rødahl, Tor Paaske Utheim, Hans Olav Ueland   +13 more
wiley   +1 more source

Teprotumumab for Thyroid-Associated Ophthalmopathy [PDF]

, 2017
BACKGROUND: Thyroid-associated ophthalmopathy, a condition commonly associated with Graves’ disease, remains inadequately treated. Current medical therapies, which primarily consist of glucocorticoids, have limited efficacy and present safety concerns ...
Antonelli, A, Couch, SM, Dailey, RA, Douglas, RS, Ezra, DG, Fleming, JC, Gabriel, K, Gigantelli, JW, Goldberg, RA, Harris, GJ, Hayek, BR, Hink, EM, Kahaly, GJ, Magni, G, Salvi, M, Shriver, EM, Smith, TJ, Tang, RA, Woodward, RM   +18 more
core   +1 more source

British Thyroid Association Survey of Graves' Disease Management in the UK

Clinical Endocrinology, EarlyView.
ABSTRACT Background Recent years have seen changes and uncertainties in evidence and guideline recommendations in Graves' disease treatment. To understand the impact of these developments on current practice, we undertook a survey of Graves' disease management in the United Kingdom and compared this to other national and international surveys.
Michael Atkinson, Medha Agrawal, Koteshwara Muralidhara, Prakash Abraham, Bijay Vaidya, Onyebuchi E. Okosieme   +5 more
wiley   +1 more source